These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38418106)

  • 1. Clinical Benefits of Oral Anticoagulants for Elderly Patients With Cardioembolic Stroke at High Bleeding Risk.
    Saito K; Hagii J; Soma T; Washima S; Yamada N; Shiroto H; Saito S; Kamada T; Takanashi S; Tomita H
    In Vivo; 2024; 38(2):725-733. PubMed ID: 38418106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High pre-stroke CHADS
    Sakai K; Suda S; Iguchi Y; Abe A; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K
    J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107519. PubMed ID: 38142567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Body Mass Index is a Poor Prognosis Factor in Cardioembolic Stroke Patients with NonValvular Atrial Fibrillation.
    Hagii J; Metoki N; Saito S; Fujita A; Shiroto H; Sasaki S; Takahashi K; Hitomi H; Baba Y; Seino S; Kamada T; Uchizawa T; Iwata M; Matsumoto S; Yasujima M; Tomita H
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3155-3162. PubMed ID: 30093200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Anticoagulants in Very Elderly Nonvalvular Atrial Fibrillation Patients With High Bleeding Risks: ANAFIE Registry.
    Okumura K; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    JACC Asia; 2022 Nov; 2(6):720-733. PubMed ID: 36444326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.
    Yamaji H; Higashiya S; Murakami T; Hina K; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):246-254. PubMed ID: 31498193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Creatinine Clearance Is a Risk Factor for Severe Cardioembolic Stroke in Japanese Female Patients.
    Sakai S; Hagii J; Shikanai S; Sorimachi Y; Hamaura S; Yamazaki K; Yamada N; Shiroto H; Saito S; Kamada T; Takanashi S; Okumura K; Tomita H
    In Vivo; 2023; 37(1):336-344. PubMed ID: 36593049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Ischemic Stroke Outcome and Preceding Anticoagulation: Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Tavares SF; Ferreira I; Chaves V; Flores L; Correia C; Almeida J; Fonseca L; Castro Chaves P
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104691. PubMed ID: 32067853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Anticoagulants in Reducing Mortality and Disability in Cardioembolic Stroke Patients.
    Jurjāns K; Cērpa M; Baborikina A; Kalējs O; Miglāne E
    Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295484
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions.
    Zhou J; Wang X; Yu J; Wu Y; Li X; Xie X; Zhang X; Cheng D; Yang B
    Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):583-593. PubMed ID: 37057840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis.
    Kim TH; Kim JY; Mun HS; Lee HY; Roh YH; Uhm JS; Pak HN; Lee MH; Joung B
    J Thromb Haemost; 2015 Feb; 13(2):182-90. PubMed ID: 25472735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Treatment Initiation With Oral Anticoagulants for Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Deguchi I; Tanahashi N; Takao M
    Circ J; 2017 Jan; 81(2):180-184. PubMed ID: 27980235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation.
    Jansson M; Själander S; Sjögren V; Björck F; Renlund H; Norrving B; Själander A
    J Thromb Thrombolysis; 2023 Apr; 55(3):415-425. PubMed ID: 36607464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
    Cappellari M; Carletti M; Danese A; Bovi P
    J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.